Search Within

Lisa Bodei

  1. "Diane Reidy"
Formats
  1. Journal Article (7)
  2. Meeting Abstract (6)
  3. Review (2)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Center for Pancreatic Cancer Research (17)
  2. Department of Medicine (17)
  3. Gastrointestinal Oncology Service (17)
  4. Molecular Imaging and Therapy Service (17)
  5. Radiology, Department of (17)
  6. Sloan Kettering Institute Postdocs (17)

More Groups

People
  1. Diane Reidy (17)
  2. Nitya Raj (9)
  3. Simone Krebs (8)
  4. Heiko Schoder (6)
  5. Joseph O'Donoghue (5)
  6. Neeta Pandit-Taskar (5)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (3)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (2)

More Years

Publications
  1. Journal of Nuclear Medicine (5)
  2. European Journal of Nuclear Medicine and Molecular Imaging (3)
  3. Pancreas (3)
  4. Clinical Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (5)
  2. Lippincott Williams & Wilkins (3)
  3. Springer (3)
  4. American Association for Cancer Research (1)
  5. American Society of Clinical Oncology (1)
  6. Nature Publishing Group (1)

More Publishers

Results (17)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients
    Review

    Strosberg, J. R.; Al-Toubah, T.; El-Haddad, G.; Lagunes, D. R.; Bodei, L.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
    Editorial

    Singh, S.; Hope, T. A.; Bergsland, E. B.; Bodei, L.; Bushnell, D. L.; Chan, J. A.; Chasen, B. R.; Chauhan, A.; Das, S.; Dasari, A.; more...
    JNCI: Journal of the National Cancer Institute (2023)

    Fulltext@MSK | Save
  • Interim analysis of a prospective validation of 2 blood-based genomic assessments (PPQ and NETest) to determine the clinical efficacy of (177)Lu-DOTATATE in neuroendocrine tumors
    Journal Article

    Bodei, L.; Raj, N.; Do, R. K.; Mauguen, A.; Krebs, S.; Reidy-Lagunes, D.; Schöder, H.
    Journal of Nuclear Medicine (2023)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to lutetium-177-DOTATATE
    Journal Article

    Raj, N.; Coffman, K.; Le, T.; Do, R. K. G.; Rafailov, J.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; more...
    Neuroendocrinology (2022)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated (WD) high-grade (HG) neuroendocrine tumors (NETs) to (177)Lu-DOTATATE
    Meeting Abstract

    Coffman, K.; Bodei, L.; Le, T.; Choi, Y.; Chou, J.; Capanu, M.; Dunphy, M.; Fox, J.; Grewal, R.; Reddy, R.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood-based genomic assessment of clinical efficacy and toxicity of (177)Lu-DOTATATE of neuroendocrine tumors
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, K. G.; Krebs, S.; Reidy-Lagunes, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schöder, H.
    Pancreas (2022)

    Fulltext@MSK | Save
  • Blood based genomic assessment of the clinical efficacy and toxicity of peptide receptor radionuclide therapy (PRRT)
    Meeting Abstract

    Bodei, L.; Raj, N.; Do, R. K. G.; Krebs, S.; Reidy, D.; Kidd, M.; Drozdov, I.; Modlin, I.; Schoder, H.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save
  • Treatment response and clinical outcomes of well-differentiated high-grade neuroendocrine tumors to 177Lu-DOTATATE
    Meeting Abstract

    Coffman, K. L.; Bodei, L.; Le, T.; Choi, Y.; Chou, J. F.; Capanu, M.; Dunphy, M.; Fox, J. J.; Grewal, R. K.; Reddy, R.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Peptide receptor radionuclide therapy during the COVID-19 pandemic: Are there any concerns?
    Correspondence

    Bodei, L.; Bergsland, E.; de Herder, W. W.; Ferone, D.; Hicks, R. J.; Hope, T. A.; Kunikowska, J.; Pavel, M.; Reidy-Lagunes, D.; Siveke, J.; more...
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save